Dr. Larry Good has been practicing gastroenterology since 1978. Dr. Good graduated Colgate University Magna Cum Laude in 1969 and received his M.D. with Alpha Omega Alpha status from the Medical University of South Carolina in Charleston, SC in 1973.
Dr. Good served a medical residency from 1973-76 and was Chief Medical Resident in 1976. He was fellowship in gastroenterology trained at the University of Pennsylvania from 1976-78.
Dr. Good has served as the Director of Liver Diseases at Nassau County Medical Center and was for many years Chief, Division of Gastroenterology , Department of Medicine at South Nassau Communities Hospital. Dr. Good is an assistant clinical professor of medicine at SUNY Stony Brook. He has given hundreds of lectures in his field and has authored numerous papers and abstracts. Dr. Good has presented the prestigious ACG Theater lecture at the American College of Gastroenterology annual meeting in Chicago, Illinois in October, 2014.
Dr. Good has been Chief Medical Officer at Ritter Pharmaceuticals in Los Angeles, California, where he expanded his research interest in the intestinal microbiome. Dr. Good's current clinical research activities involve the microbiome, inflammatory bowel disease, irritable bowel syndrome and the application of orally administered gamma globulin to patients with acute and chronic gastrointestinal disorders.
Dr. Good founded Good Pharmaceutical Development Co., LLC, in 2014. He is their CEO and has developed a topical product for treating neuropathic pain. Good Pharmaceutical Company is now marketing three products that are based on phytocannabinoid pharmaceutical grade extraction and manufacture including a topical cream, a topical patch and an oral tincture for the management of irritable bowel syndrome.
Dr. Good was appointed as an editor of BMC Gastroenterology, a prestigious online peer reviewed medical journal. Dr. Good continues to actively pursue clinical research in his areas of interest and is presenting a paper at the 2023 American College Of Gastroenterology meeting describing a novel phytocannabinoid preparation for irritable bowel syndrome.
Dr. Good is the former CEO of Compassionate Care Center of NY and has had a long interest in research application of the physiology of natural molecules to multiple disease states. Dr. Good remains actively involved in his medical practice with a consultative gastroenterology and endoscopic practice as well as a robust Concierge Choice internal medicine practice. Dr. Good is still accepting new patients in his medical practice.
Qualifications and Experience